Author:
Khrunin A V,Moisseev A,Gorbunova V,Limborska S
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine
Reference53 articles.
1. Kelland L . The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 2007; 7: 573–584.
2. Rabik CA, Dolan ME . Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 2007; 33: 9–23.
3. Evans WE, McLeod HL . Pharmacogenomics—drug disposition, drug targets, and side effects. N Engl J Med 2003; 348: 538–548.
4. Yamayoshi Y, Iida E, Tanigawara Y . Cancer pharmacogenomics: international trends. Int J Clin Oncol 2005; 10: 5–13.
5. Yu JJ, Lee KB, Mu C, Li Q, Abernathy TV, Bostick-Bruton F et al. Comparison of two human ovarian carcinoma cell lines (A2780/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene. Int J Oncol 2000; 16: 555–560.
Cited by
150 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献